Alcon AG reported $795M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AstraZeneca USD 5.16B 510M Jun/2026
Bayer EUR 2.14B 2.31B Jun/2026
Essilor EUR 4.34B 1.25B Jun/2026
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Philips EUR 910M 343M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025